Literature DB >> 17481551

5-lipoxygenase: regulation and possible involvement in atherosclerosis.

Olof Rådmark1, Bengt Samuelsson.   

Abstract

This review article focuses on two aspects regarding 5-lipoxygenase. First, mechanisms for activation of the enzyme. Second, the involvement of 5-lipoxygenase and leukotrienes in atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17481551     DOI: 10.1016/j.prostaglandins.2007.01.003

Source DB:  PubMed          Journal:  Prostaglandins Other Lipid Mediat        ISSN: 1098-8823            Impact factor:   3.072


  20 in total

1.  Leukotriene B4 receptor-1 mediates intermittent hypoxia-induced atherogenesis.

Authors:  Richard C Li; Bodduluri Haribabu; Steven P Mathis; Jinkwan Kim; David Gozal
Journal:  Am J Respir Crit Care Med       Date:  2011-04-14       Impact factor: 21.405

2.  Discovery of potent and selective inhibitors of human platelet-type 12- lipoxygenase.

Authors:  Victor Kenyon; Ganesha Rai; Ajit Jadhav; Lena Schultz; Michelle Armstrong; J Brian Jameson; Steven Perry; Netra Joshi; James M Bougie; William Leister; David A Taylor-Fishwick; Jerry L Nadler; Michael Holinstat; Anton Simeonov; David J Maloney; Theodore R Holman
Journal:  J Med Chem       Date:  2011-07-08       Impact factor: 7.446

3.  Anti-inflammatory activity of copao (Eulychnia acida Phil., Cactaceae) fruits.

Authors:  Felipe Jiménez-Aspee; Maria Rosa Alberto; Cristina Quispe; Maria del Pilar Caramantin Soriano; Cristina Theoduloz; Iris Catiana Zampini; Maria Ines Isla; Guillermo Schmeda-Hirschmann
Journal:  Plant Foods Hum Nutr       Date:  2015-06       Impact factor: 3.921

Review 4.  Polyunsaturated fatty acids and cardiovascular disease: implications for nutrigenetics.

Authors:  Hooman Allayee; Nitzan Roth; Howard N Hodis
Journal:  J Nutrigenet Nutrigenomics       Date:  2009-09-23

Review 5.  Leukotrienes in atherosclerosis: new target insights and future therapy perspectives.

Authors:  Graziano Riccioni; Alessandra Zanasi; Nicola Vitulano; Barbara Mancini; Nicolantonio D'Orazio
Journal:  Mediators Inflamm       Date:  2010-01-26       Impact factor: 4.711

6.  Effects of MK-886, a 5-lipoxygenase activating protein (FLAP) inhibitor, and 5-lipoxygenase deficiency on the forced swimming behavior of mice.

Authors:  Tolga Uz; Nikola Dimitrijevic; Marta Imbesi; Hari Manev; Radmila Manev
Journal:  Neurosci Lett       Date:  2008-03-21       Impact factor: 3.046

7.  The Role of Immunogenicity in Cardiovascular Disease.

Authors:  Michael Jan; Anthony T Virtue; Meghanaben Pansuria; Jingshan Liu; Xinyu Xiong; Pu Fang; Shu Meng; Hong Wang; Xiao-Feng Yang
Journal:  World Heart J       Date:  2011-01-01

Review 8.  The LDL modification hypothesis of atherogenesis: an update.

Authors:  Daniel Steinberg
Journal:  J Lipid Res       Date:  2008-11-15       Impact factor: 5.922

9.  The 5-lipoxygenase as a common pathway for pathological brain and vascular aging.

Authors:  Jin Chu; Domenico Praticò
Journal:  Cardiovasc Psychiatry Neurol       Date:  2009-09-01

10.  5-Lipoxygenase DNA methylation and mRNA content in the brain and heart of young and old mice.

Authors:  Svetlana Dzitoyeva; Marta Imbesi; Louisa W Ng; Hari Manev
Journal:  Neural Plast       Date:  2009-12-13       Impact factor: 3.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.